Growing a human “organ” in a lab used to sound like science fiction. Today, organoids are a mainstream research tool in biology and medicine. In a 2022 primer in Nature Reviews Methods Primers, Zhao and colleagues define an organoid as a self-organized, three-dimensional tissue that is typically derived from stem cells and mimics key features of an organ. Organoids do not replace real organs, but they can model important parts of how tissues develop, function, and fail in disease.
How Organoids Differ from 2D Cell Culture
Most classic lab experiments grow cells on flat plastic dishes in two dimensions (2D). Real human tissues are not flat. Cells in the body exist in 3D environments, where they interact with neighbors, experience gradients of nutrients and signals, and organize into tissue-like structures. Organoids partially recreate that 3D organization, which is why they can sometimes capture behaviors that 2D cultures miss. The Nature Reviews Methods Primers primer emphasizes that organoids can be derived from different stem cell sources and can be engineered with strategies that support growth, differentiation, and maturation.
Case Study: Patient-Derived Organoids and Personalized Treatment Testing
One of the most practical directions for organoids is patient-derived organoids (PDOs), especially in cancer. Cells taken from a patient’s tumor can be grown into a 3D organoid, and researchers can test how that organoid responds to different therapies. The 2022 Nature Reviews Methods Primers overview discusses tumor organoids as a way to model disease and capture patient-to-patient differences. What makes this especially notable is that organoids are now being tested in real clinical research settings.On the U.S. National Library of Medicine’s ClinicalTrials.gov registry, a study titled “Organoid-based Functional …” (NCT06102824) states that it aims to gather evidence for using patient-derived organoids to personalize treatment strategies and guide clinical decisions. Even though trials like this are still developing, the existence of registered studies shows how organoids are being positioned as tools that could eventually support real treatment decisions.
Brain Organoids and “Organoid Intelligence”
Organoids become even more controversial and headline-worthy when they involve the brain. Some researchers have proposed connecting brain organoids to interfaces that can record and stimulate activity, creating a field sometimes called organoid intelligence (OI). In a 2023 article in Frontiers in Science, Smirnova and colleagues describe organoid intelligence as an emerging multidisciplinary effort to develop biological computing using brain organoids and brain–machine interface technologies. However, this field raises ethical questions that are as significant as its scientific promise. A 2025 consensus paper titled Ethics and regulation of human brain organoid research: recommendations from the Asia Pacific Neuroethics Working Group outlines ethical and regulatory considerations for this area and emphasizes the need for governance that can adapt as the science changes.
Organoids have become one of the most influential tools in modern biology because they sit between simple cell culture and real human organs. They can self-organize into 3D tissue-like structures and mimic key organ features, making them useful for studying development and disease. Patient-derived organoids are already being tested in clinical research settings as a way to inform personalized treatment strategies. At the same time, brain organoids and “organoid intelligence” show how quickly this technology pushes science into new territory where ethical guidance must keep pace with innovation.
